SHL Medical joins Pre-filled Syringes and Injection Devices in La Jolla, California

SHL Medical is pleased to announce our debut at Pre-filled Syringes and Injection Devices 2025, taking place on December 9-10 at the Sheraton in La Jolla, California.

Following the successful introduction of our Reunite™ autoinjector, we are bringing the device to the West Coast to engage with pharma and biotech partners on next-generation combination product development. Reunite is an innovative, three-step, dual-chamber cartridge autoinjector, built with our proprietary Needle isolation Technology (NIT®). The device is designed to support the automated reconstitution and delivery of lyophilized formulations.

Explore Reunite alongside our flagship Molly® modular platform autoinjectors, which has supported 22 distinct combination product approvals across a wide range of indications, including therapies in the rapidly growing GLP-1 segment. Also on display will be Maggie®, our cartridge-based autoinjector built with NIT®, supporting the delivery of large-volume and complex biologics.

Earlier this year, we celebrated the grand opening of our 360,000-square-foot facility in North Charleston, South Carolina, strengthening our US presence and supply chain resiliency. This site complements our operations in Deerfield Beach, Florida, which provides final assembly, labeling, and packaging services. Together, these sites reinforce our manufacturing capabilities to deliver advanced self-injection solutions across North America and beyond.

Having achieved 1.5 billion autoinjectors shipped worldwide, SHL Medical continues to expand its global manufacturing capabilities to meet rising demand. Visit us to connect with our team and learn how we are advancing innovation and expanding manufacturing footprint in the evolving landscape of self-injection solutions.

Join the event and meet our team in La Jolla.

Where : Sheraton La Jolla, CA, USA

When   : December 9-10